英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
interdependencies查看　interdependencies　在百度字典中的解释百度英翻中〔查看〕
interdependencies查看　interdependencies　在Google字典中的解释Google英翻中〔查看〕
interdependencies查看　interdependencies　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • P200049. Letter - Food and Drug Administration
    This device is a percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in patients who have nonvalvular atrial fibrillation and who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2‐VASc scores, are suitable for short term anticoagulation
  • Amplatzer™ Amulet™ Left Atrial Appendage Occluder 510 (k) FDA Approval
    The amplatzer™ amulet™ left atrial appendage occluder may be considered for use in patients who are at increased risk for stroke and systemic embolism based on chads2 or cha2ds2-vasc scores, suitable for short term anticoagulation therapy, and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation, taking
  • Amplatzer Amulet LAA Occluder | Abbott
    The Amplatzer™ Amulet™ Left Atrial Appendage Occluder is a percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA)
  • 14886 Federal Register Vol. 89, No. 41 Thursday, February 29 . . . - GovInfo
    (3)(B) FDA has approved for marketing the medical device AMPLATZER AMULET AMPLATZER AMULET is indicated to reduce the risk of thrombus embolization from the left atrial appendage in patients who have nonvalvular atrial fibrillation and who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2–VASc scores, are
  • P200049 SSED - Food and Drug Administration
    The AmplatzerTM AmuletTM Left Atrial Appendage Occluder is a percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in patients who have nonvalvular atrial fibrillation and who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores, are suitable for short term anticoagulation therapy
  • Premarket Approval (PMA) - Food and Drug Administration
    Page Last Updated: 03 23 2026 Note: If you need help accessing information in different file formats, see Language Assistance Available: | | | | | | | | | | | | | | |
  • Abbott Amplatzer Amulet Left Atrial Appendage Occluder . . . - Manuals+
    The AmplatzerTM AmuletTM Left Atrial Appendage Occluder is a percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in patients who have nonvalvular atrial fibrillation and who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores, are suitable for short-term anticoagulation therapy
  • Premarket Approval (PMA) - accessdata. fda. gov
    Premarket Approval (PMA) FDA Home Medical Devices Databases
  • Food and Drug Administration
    Food and Drug Administration
  • AMPLATZER™ Amulet™ LAA Occluder Trial (Amulet IDE) - ClinicalTrials. gov
    Deemed by investigator to be suitable for short term warfarin therapy but deemed unable to take long term oral anticoagulation, following the conclusion of shared decision making (see inclusion criteria #6)
  • Abbotts Amplatzer™ Amulet™ Device Approved by FDA to Treat People With . . .
    The FDA approval is supported by findings from the Amulet IDE trial, a large-scale randomized head-to-head study comparing Amulet with an alternative minimally invasive LAA occlusion device, which will be virtually presented at the European Society of Cardiology (ESC) 2021 Congress on August 30, 2021





中文字典-英文字典  2005-2009